Zepp Health Corp
Close on Oct 19, 2026
About Zepp Health
Electronic Computers, SIC 3571
Zepp Health Corporation develops, manufactures, and sells smart wearable devices and health technology products. Its primary offerings include smartwatches and fitness bands sold under the Amazfit and Zepp brands across adventure, performance, lifestyle, and essential categories. The company also produces complementary hardware such as smart rings, hearing aids, earbuds, and smart scales, alongside proprietary operating software and mobile applications that track biometric and fitness data. Additionally, it provides digital sound wellness services and data analytics. Its products serve individual consumers, fitness enthusiasts, athletes, outdoor explorers, and healthcare providers.
The business maintains operational activities in Europe, the United States, and Asia, with principal executive offices situated in Gorinchem, Netherlands. It has shipped over 200 million smart wearable units worldwide, with device activations across more than 150 countries and users in over 90 countries. Furthermore, the company reports over 389 million registered mobile application users and employs 465 research and development personnel.
Summary of the business section of Zepp Health's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Zepp Health Corp
- Founded
- 2013
- Headquarters
- Hefei, China
- Address
- Building B2, Zhong'An Chuanggu, Technology Park No.900 Wangjiang West Rd 230088
- Phone
- 86551-65837200
- Website
- zepp.com
- Employees
- 465, Dec 31, 2025
- Industry
- Electronic Computers
- Incorporated in
- E9
- Fiscal year ends
- December 31
- Auditor
- Deloitte Touche Tohmatsu Certified Public Accountants LLP, Beijing, the Peoples Republic of China
Stock & identifiers
- Ticker
- ZEPP
- Exchange
- NYSE
- IPO date
- Feb 9, 2018
- Shares outstanding
- 235M, Dec 31, 2025
- Filer category
- Non-accelerated filer
- Stock splits
- 1-for-4 reverse, Sep 16, 2024
- SEC CIK
- 1720446
- CUSIP
- 98945L204
- ISIN
- US98945L2043
- LEI
- 529900B5C2R4FTJCRN49
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Wang Huang | Chief Executive Officer, Director | 66,134,256 |
| Mike Yan Yeung | Chief Operating Officer, Director | 954,613 |
| Pengtao Yu | Chief Industrial Designer | 98,491 |
| Meihui FAN | Chief Technology Officer | 4,412,746 |
| Cheng Deng | Chief Financial Officer | 124,375 |
| hui wang | VP of Corporate Strategy | 1,495,500 |
| Bing (Brian) Xie | Director | – |
| Jimmy Y. Lai | Director | – |
| Sai Wai Alain Lam | Director | – |
| HongJiang Zhang | Director | – |
Employees
Headcount reported in annual reports
“As of December 31, 2025, our total research and development staff consisted of 465 employees.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Feb 25, 2021 | Name change | Name changed from Huami Corp to Zepp Health Corp |
| Feb 9, 2018 | IPO | Initial public offering priced (424B4 prospectus) |
| Jan 26, 2018 | Listing | Registration of securities on an exchange (Form 8-A) |